van Rhijn BW - Search Results

1

Consecutive quantitative cytology in bladder cancer.

van der Poel HG, van Rhijn BW, Peelen P, Debruyne FM, Boon ME, Schalken JA. van der Poel HG, et al. Among authors: van rhijn bw. Urology. 2000 Oct 1;56(4):584-8. doi: 10.1016/s0090-4295(00)00726-3. Urology. 2000. PMID: 11018610

2

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: van der poel hg. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

3

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Cancer Res. 2001 Feb 15;61(4):1265-8. Cancer Res. 2001. PMID: 11245416

4

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial.

van Rhijn BW, Lurkin I, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Cancer. 2001 Aug 15;92(4):768-75. doi: 10.1002/1097-0142(20010815)92:4<768::aid-cncr1381>3.0.co;2-c. Cancer. 2001. PMID: 11550146

5

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

van Rhijn BW, Smit M, van Geenen D, Wijnmaalen A, Kirkels WJ, van der Kwast TH, Kuenen-Boumeester V, Zwarthoff EC. van Rhijn BW, et al. Among authors: van geenen d, van der kwast th. Eur Urol. 2003 Apr;43(4):369-73. doi: 10.1016/s0302-2838(03)00059-9. Eur Urol. 2003. PMID: 12667717

6

Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy.

Schrier BP, Hollander MP, van Rhijn BW, Kiemeney LA, Witjes JA. Schrier BP, et al. Among authors: van rhijn bw. Eur Urol. 2004 Mar;45(3):292-6. doi: 10.1016/j.eururo.2003.10.006. Eur Urol. 2004. PMID: 15036673

7

Urine markers for bladder cancer surveillance: a systematic review.

van Rhijn BW, van der Poel HG, van der Kwast TH. van Rhijn BW, et al. Among authors: van der kwast th, van der poel hg. Eur Urol. 2005 Jun;47(6):736-48. doi: 10.1016/j.eururo.2005.03.014. Epub 2005 Mar 23. Eur Urol. 2005. PMID: 15925067 Review.

8

Considerations on the use of urine markers for bladder cancer.

van Rhijn BW. van Rhijn BW. Eur Urol. 2008 May;53(5):880-1. doi: 10.1016/j.eururo.2008.01.043. Epub 2008 Jan 22. Eur Urol. 2008. PMID: 18222604 No abstract available.

9

Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?

de Bekker-Grob EW, van der Aa MN, Zwarthoff EC, Eijkemans MJ, van Rhijn BW, van der Kwast TH, Steyerberg EW. de Bekker-Grob EW, et al. Among authors: van rhijn bw, van der aa mn, van der kwast th. BJU Int. 2009 Jul;104(1):41-7. doi: 10.1111/j.1464-410X.2008.08323.x. Epub 2008 Dec 19. BJU Int. 2009. PMID: 19500328 Free article. Clinical Trial.

10

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR. van Rhijn BW, et al. Eur Urol. 2009 Sep;56(3):430-42. doi: 10.1016/j.eururo.2009.06.028. Epub 2009 Jun 26. Eur Urol. 2009. PMID: 19576682 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page